Enel Health®Atlas
Sign in
Enel Health®Atlas
Browse libraries

Not medical advice. The Atlas is not a substitute for a clinician who can examine you.

Quercetin

Quercetin, a Flavonoid Marketed for Prostatitis, Fertility and 'Anti-Estrogen' Effects

Evidence grade 3 of 5, Mixed. Read how the Atlas grades evidence.

The written rationale for this grade is still being prepared.

FDA
Not FDA approved; sold as a dietary supplement

Reference only. Not medical advice.

What can go wrong

Generally safe at typical supplement doses; high doses have caused headache and GI upset, and rare reports of nephrotoxicity exist with very high intake. Quercetin inhibits CYP3A4 and P-glycoprotein and can raise levels of some drugs; caution with narrow-therapeutic-index medications. Bioavailability-enhanced forms (with bromelain or phytosome delivery) change exposure.

This is something to take to a clinician. The Atlas can tell you what is known about quercetin in general. It cannot tell you what is happening in your body, and the difference matters most for exactly the symptoms that bring people to this page.

Quercetin is a dietary flavonoid with anti-inflammatory and antioxidant activity. Its strongest men's-health evidence is Shoskes et al. (1999, Urology), a small double-blind RCT (n=30) in which quercetin 500 mg twice daily significantly improved NIH-CPSI symptom scores in category III chronic prostatitis/chronic pelvic pain syndrome versus placebo. Beyond that specific indication, quercetin is marketed more speculatively for testosterone/anti-aromatase support, immunity, and athletic performance, where human evidence in men is thin. Poor oral bioavailability is a persistent limitation.

A genuine small RCT in chronic prostatitis, stretched into vaguer men's-health claims.

What people take it for

These are the reasons people give for taking it. They are not effects it has been shown to have.

  • Chronic prostatitis / chronic pelvic pain syndrome (category III)
  • Sperm/antioxidant support (adjunct, weak)
  • Purported anti-aromatase / testosterone support (unproven)
  • Allergy, immunity, exercise (separate claims)

How it is supposed to work

Quercetin inhibits pro-inflammatory mediators (including prostaglandin E2, shown as a surrogate in prostatic secretions), stabilizes mast cells, and scavenges reactive oxygen species. In prostatitis this anti-inflammatory action is the plausible mechanism. Aromatase inhibition seen in vitro underlies the 'anti-estrogen' marketing, but does not translate to hormonal effects at achievable oral doses.

One good indication, many extrapolations

The prostatitis RCT is legitimate but small and specific to category III CP/CPPS. Marketers extrapolate quercetin's in-vitro aromatase inhibition into a testosterone-boosting claim, but oral quercetin's low bioavailability and rapid metabolism mean the in-vitro potency does not produce measurable androgen changes in men, mirroring the chrysin problem.

What people get wrong

  • Often saidQuercetin lowers estrogen and raises testosterone

    ActuallyIn-vitro aromatase inhibition does not translate to measurable hormonal change at oral doses; this is an extrapolation, not a proven effect.

  • Often saidIt is a proven fertility treatment

    ActuallyIts best evidence is for prostatitis symptoms, not for fertility outcomes.

Who profits, and who pushes back

Nobody is named here yet, because we have not done that work on this entry. Read that as unfinished. Somebody almost certainly sells this, and somebody almost certainly disputes it. Assume both until we have checked.

Set against the alternatives

For CP/CPPS, quercetin is one of several adjuncts (alongside pollen extract, alpha-blockers, and multimodal UPOINT-directed therapy); for testosterone claims it is as unconvincing as chrysin. Its prostatitis niche is where the evidence actually lives.

What we do not know

  • Do bioavailability-enhanced forms improve clinical outcomes?
  • Is there any reproducible hormonal effect in men, or is the anti-aromatase claim inert orally?

The market for this

What follows describes how this is bought and sold. It is not a buying guide and it is not an endorsement of any seller.

Most supplemental quercetin is quercetin dihydrate from Sophora japonica or citrus. Purity is generally good, but plain quercetin is poorly absorbed; phytosome and enzyme-co-formulated products differ meaningfully in exposure, a difference the label rarely quantifies.

At a glance

Anchor trial
Shoskes 1999, Urology, n=30, 500 mg BID
Best-supported use
Chronic prostatitis/CPPS (category III)
Limitation
Low oral bioavailability

What this entry does not yet cover

What follows is unfinished work on our side, not a finding about Quercetin. A short entry is not a safe entry.

  • Timeline. We have not built the dated record of research and regulatory events.
  • Cost and market. We have not documented what it sells for or who sells it.
  • Supply chain. We have not mapped where it is made.
  • Who uses it. We have not documented the user groups.
  • What could change. No forward-looking summary yet.
  • Children and teenagers. We have not checked what is known about younger people.
  • Where we land. We have not taken a position on this yet.

Sources

The studies below are named and described, but not linked. You cannot open them from here and check our reading against them, which means this page is our summary of the literature rather than a document you can verify. Weigh it accordingly until the links exist.

The studies that matter

  • Shoskes et al., Urology (quercetin in category III prostatitis)1999

    500 mg BID for 1 month improved NIH-CPSI scores vs placebo (n=30)

  • Follow-up mechanistic work (PGE2 in prostatic secretions)1999-2000s

    Quercetin reduced markers of prostatic inflammation

  • In-vitro aromatase and antioxidant studiesvarious

    Activity in vitro that does not reliably translate to hormonal effects orally